Manage BPH Symptoms Effectively with Flosure 0.4mg
Flosure 0.4mg is a widely prescribed medication that contains Tamsulosin Hydrochloride, a selective alpha-1 blocker. It is primarily us...
29
Aug
Blog
28
Aug
Ivosenib 250 mg (Ivosidenib): Enhancing Survival Rates in AML & Cholangiocarcinoma
Ivosenib 250mg is a targeted cancer therapy that contains Ivosidenib, an oral, small-molecule inhibitor designed to block the activity ...
27
Aug
Dissolve Gallstones Naturally with Udiliva 150mg
Ursodeoxycholic Acid (UDCA), which is included in Udiliva 150mg, is a commonly prescribed hepatoprotective drug used to treat a number ...
26
Aug
The Versatile Role of Revlixen 10mg in Cancer Therapy
Revlixen 10mg, Lenalidomide Capsules
Revlixen 10mg is a brand-name formulation of Lenalidomide, an immunomodulatory drug widely used i...
25
Aug
Abiraxen Tablets: Hope for Metastatic Prostate Cancer
Abiraxen 250mg is a prescription medication that contains Abiraterone Acetate, a drug used in the management of prostate cancer, specif...
23
Aug
What to Know About Calupros 50mg and Prostate Cancer
Calupros 50mg, Bicalutamide Tablets
Calupros 50mg contains Bicalutamide, a non-steroidal anti-androgen medication used primarily in th...
22
Aug
Erdafixen 4mg (Erdafitinib): Advancing Personalized Cancer Treatment
Erdafixen 4mg is a targeted cancer therapy medication containing Erdafitinib, a potent and selective fibroblast growth factor receptor ...
21
Aug
Enasinib 50mg: Promoting Differentiation in AML Cells
Enasinib 50mg contains Enasidenib, a targeted cancer therapy used in the treatment of certain types of leukemia. Developed as part of t...
20
Aug
Pemitinib 13.5mg: The Future of FGFR-Focused Cancer Therapies
Pemitinib 13.5mg is a targeted cancer therapy that contains Pemigatinib, a selective inhibitor of fibroblast growth factor receptors (F...
19
Aug
Adakras 200mg Targeted Therapy for KRAS G12C Mutation in NSCLC
Adakras 200mg is a generic formulation of Adagrasib, a targeted therapy. Adagrasib is an oral, irreversible inhibitor of the KRAS G12C ...
18
Aug
Talaparib 1mg: A New Era of Precision Oncology and Targeted Therapy
Talaparib 1mg, containing the active substance Talazoparib, is an oral targeted cancer therapy belonging to the class of PARP inhibitor...
06
Jun
LuciBelu 200mg, Belumosudil Tablets
Belumosudil, marketed under the brand name LuciBelu 200 mg, is a selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2). It...